» Articles » PMID: 7330947

Treatment of Proliferative Sparganosis with Mebendazole and Praziquantel

Overview
Date 1981 Jan 1
PMID 7330947
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

The serum IgG antibody level as a biomarker for clinical outcome in patients with cerebral sparganosis after treatment.

Xiang H, Wang J, Tan D, Xiong Y, Huang P, Shen Y Front Immunol. 2023; 14:1158635.

PMID: 37051247 PMC: 10083495. DOI: 10.3389/fimmu.2023.1158635.


Diagnosis and management of cerebral sparganosis: An uncommon parasitic infection of the brain.

Yang E, Lee J, Patel V Radiol Case Rep. 2022; 17(6):1874-1880.

PMID: 35401890 PMC: 8990059. DOI: 10.1016/j.radcr.2022.02.084.


Surgical treatment of a patient with live intracranial sparganosis for 17 years.

Hu J, Liao K, Feng X, Jiang D, Liu H, Zheng Q BMC Infect Dis. 2022; 22(1):353.

PMID: 35397512 PMC: 8994396. DOI: 10.1186/s12879-022-07293-7.


Sparganosis mimicking a soft-tissue tumor: A diagnostic challenge.

Sharma S, Mahajan R, Ram H, Karikalan M, Achra A Trop Parasitol. 2021; 11(1):49-52.

PMID: 34195062 PMC: 8213118. DOI: 10.4103/tp.TP_40_20.


Follow-up study of high-dose praziquantel therapy for cerebral sparganosis.

Zhang P, Zou Y, Yu F, Wang Z, Lv H, Liu X PLoS Negl Trop Dis. 2019; 13(1):e0007018.

PMID: 30640909 PMC: 6331082. DOI: 10.1371/journal.pntd.0007018.